Literature DB >> 23107443

Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters.

Zhi Xia Dong1, Hui Juan Zhou, Jian Hua Wang, Xiao Gang Xiang, Yan Zhuang, Si Min Guo, Hong Lian Gui, Gang De Zhao, Wei Liang Tang, Hui Wang, Qing Xie.   

Abstract

OBJECTIVE: This study aimed to explore the most up-to-date distribution of hepatitis C virus (HCV) genotypes in China, especially the association between HCV genotypes and patients' characteristics and clinical parameters.
METHODS: Sera from 483 HCV antibody-positive patients were genotyped using a HCV genotyping chip assay. The distribution of HCV genotypes, clinical parameters, modes of transmission and duration of infection were determined and the relationships among these parameters were analyzed.
RESULTS: A total of 424 patients were successfully genotyped. HCV genotypes 1, 2, 3 and 6 were found with a constituent ratio of 72.1%, 12.3%, 10.6% and 5.0%, respectively, in which subtypes 1b (69.1%), 2a (11.6%) and 3a (7.5%) were prevalent. The mean age of patients with genotype 1 and 2 was significantly elder than those with genotype 3 and 6 (P < 0.05). The distribution of HCV genotypes in relation to the mode of HCV transmission was remarkable (P < 0.001). Transfusion of blood and blood products was the main mode of transmission. Most genotype 1 infection (53.1%) was found in the group with a duration of HCV infection of 10-20 years. Genotype 1b was independently associated with age (P = 0.001) and mode of HCV transmission (P = 0.007).
CONCLUSIONS: The main HCV subtype was genotype 1b in Chinese patients. The prevalence of HCV genotypes was correlated with age and the mode of HCV transmission. Genotype 3a and 6 may become an increasing threat in the future.
© 2012 The Authors. Journal of Digestive Diseases © 2012 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23107443     DOI: 10.1111/j.1751-2980.2012.00636.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  9 in total

1.  Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.

Authors:  Yan-Feng Pan; Yan Zheng; Tao Qin; Lei Feng; Qian Zhang; Xiao-Gong Ping; Yan-Ting Pan; Xiao-Ping Wang; Li Bai; Hua-Hua Li
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

2.  Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020.

Authors:  Jia Yang; Hui-Xin Liu; Ying-Ying Su; Zhi-Sheng Liang; Hui-Ying Rao
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

3.  Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.

Authors:  Y Wang; X D Tan; C Zhou; W Zhou; J S Peng; Y S Ren; Z L Ni; B Liu; F Yang; X D Gao
Journal:  Epidemiol Infect       Date:  2016-07-13       Impact factor: 4.434

4.  Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Aghnaya A Dau
Journal:  BMC Res Notes       Date:  2015-08-21

Review 5.  Current challenges and the management of chronic hepatitis C in mainland China.

Authors:  Zhongping Duan; Ji-Dong Jia; Jinlin Hou; Lillian Lou; Hillel Tobias; Xiao Yuan Xu; Lai Wei; Hui Zhuang; Calvin Q Pan
Journal:  J Clin Gastroenterol       Date:  2014-09       Impact factor: 3.062

Review 6.  Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.

Authors:  Yu Zhang; Li-Min Chen; Miao He
Journal:  Virol J       Date:  2017-02-23       Impact factor: 4.099

Review 7.  Diabetes and Hepatitis C: A Two-Way Association.

Authors:  Sara Salehi Hammerstad; Shira Frankel Grock; Hanna J Lee; Alia Hasham; Nina Sundaram; Yaron Tomer
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-14       Impact factor: 5.555

8.  Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.

Authors:  Xia Rong; Ru Xu; Huaping Xiong; Min Wang; Ke Huang; Qiuyu Chen; Chengyao Li; Qiao Liao; Jieting Huang; Wenjie Xia; Guangping Luo; Xin Ye; Ming Zhang; Yongshui Fu
Journal:  Arch Virol       Date:  2014-08-02       Impact factor: 2.574

9.  Evolving Diversity of Hepatitis C Viruses in Yunnan Honghe, China.

Authors:  Lanhui Yang; Chenyan Jiang; Song Hu; Qiongni Diao; Jia Li; Wei Si; Mei Chen; Richard Y Zhao
Journal:  Int J Mol Sci       Date:  2016-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.